HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption-Reference-Cited by-同舟云学术

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Published:2016-06-22 Issue:7613 Volume:535 Page:556-560
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Scheid Johannes F.,Horwitz Joshua A.,Bar-On Yotam,Kreider Edward F.,Lu Ching-Lan,Lorenzi Julio C. C.,Feldmann Anna,Braunschweig Malte,Nogueira Lilian,Oliveira Thiago,Shimeliovich Irina,Patel Roshni,Burke Leah,Cohen Yehuda Z.,Hadrigan Sonya,Settler Allison,Witmer-Pack Maggi,West, Anthony P.,Juelg Boris,Keler Tibor,Hawthorne Thomas,Zingman Barry,Gulick Roy M.,Pfeifer Nico,Learn Gerald H.,Seaman Michael S.,Bjorkman Pamela J.,Klein Florian,Schlesinger Sarah J.,Walker Bruce D.,Hahn Beatrice H.,Nussenzweig Michel C.,Caskey Marina

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature18929.pdf

Reference52 articles.

1. Scheid, J. F. et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding. Science, doi:science.1207227 [pii] 10.1126/science.1207227 (2011)

2. Scheid, J. F. et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458, 636–640, doi:nature07930 [pii] 10.1038/nature07930 (2009)

3. Klein, F. et al. Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199–1204, doi:10.1126/science.1241144 (2013)

4. Barouch, D. H. et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224–228, doi:10.1038/nature12744 (2013)

5. Halper-Stromberg, A. et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 158, 989–999, doi:10.1016/j.cell.2014.07.043 (2014)

Cited by 409 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production and characterization of novel Anti-HIV Fc-fusion proteins in plant-based systems: Nicotiana benthamiana & tobacco BY-2 cell suspension;New Biotechnology;2024-11

2. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity;Journal of Virology;2024-09-09

3. HIV Cure: How Far We Have Come?;Indian Journal of Microbiology;2024-08-13

4. The impact of analytical treatment interruptions and trial interventions on time to viral re‐suppression in people living with HIV restarting ART in cure‐related clinical studies: a systematic review and meta‐analysis;Journal of the International AIDS Society;2024-08

5. Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines;Cell Reports Medicine;2024-08